FDA — authorised 13 March 2024
- Application: BLA761232
- Marketing authorisation holder: BEIGENE
- Local brand name: TEVIMBRA
- Indication: INJECTION — SOLUTION
- Status: approved
🇺🇸 TEVIMBRA in United States
FDA authorised TEVIMBRA on 13 March 2024
Marketing authorisations
FDA
- Status: approved
TEVIMBRA in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is TEVIMBRA approved in United States?
Yes. FDA authorised it on 13 March 2024; FDA has authorised it.
Who is the marketing authorisation holder for TEVIMBRA in United States?
BEIGENE holds the US marketing authorisation.